Presentation Information
[3LBA-0152]Synergistic Antimyeloma Activity of Pomalidomide and Selinexor through Hyperactivation of Type I Interferon–JAK–STAT Signaling
○Junichi Yamamoto1, Yuki Yamaguchi1 (1. Institute of Science Tokyo)
Password required to view
Password required to view or download.
Check your name badge for the password.
Check your name badge for the password.
Comment
To browse or post comments, you must log in.Log in
